Bone marrow cells are targets for the anabolic actions of prostaglandin E2 on bone: Induction of a transition from nonadherent to adherent osteoblast precursors
Open Access
- 1 March 1995
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 10 (3) , 474-487
- https://doi.org/10.1002/jbmr.5650100320
Abstract
Although prostaglandin E2 (PGE2) is known to stimulate bone formation in vivo, its mechanism of action is not well understood. Circumstantial evidence suggests that bone marrow cells (BMC) may well be involved in this, and in order to investigate this further we have studied the effect of PGE2 on proliferation and matrix synthesis in high-density BMC cultures and on colony-forming unit (CFU-f) formation efficiency by BMC in vitro. High-density cultures of BMC formed a collagenous, calcified matrix, synthesized osteocalcin and expressed alkaline phosphatase activity. The addition of PGE2 caused a concentration-dependent increase in total (but not specific) APase activity, cell number, and collagen accumulation. It was found that PGE2 need only be present during the first 48 hours of the culture period and that longer exposure had no additional effect PGE2 also caused a concentration-dependent increase in CFU-f formation, and it was found that this was due to the recruitment of new mesenchymal precursor cells from the nonadherent fraction of the BMC. Once again, the presence of PGE2 for only the first 48 hours of the culture period was enough to precipitate a maximal response. We conclude that one mechanism for the anabolic actions of PGE2 may be the recruitment of OB precursors from a population of nonadherent mesenchymal precursor cells present in the bone marrow.Keywords
This publication has 61 references indexed in Scilit:
- Calcium homeostasis and hypercalciuria in hyperprostaglandin E syndromeThe Journal of Pediatrics, 1992
- Cross-talk regulation between cyclic AMP production and phosphoinositide hydrolysis induced by prostaglandin E2 in osteoblast-like cellsExperimental Cell Research, 1992
- Effect of prostaglandins E1, E2, and F2α on osteoclast formation in mouse bone marrow culturesJournal of Bone and Mineral Research, 1991
- Determination of numbers of osteoprogenitors present in isolated fetal rat calvaria cells in vitroDevelopmental Biology, 1989
- Generation of osteoclasts in cultures of rabbit bone marrow and spleen cellsJournal of Cellular Physiology, 1987
- Prostaglandin E2 stimulates DNA synthesis by a cyclic AMP‐independent pathway in osteoblastic clone MC3T3‐E1 cellsJournal of Cellular Physiology, 1986
- A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections.Journal of Histochemistry & Cytochemistry, 1985
- Direct effect of parathyroid hormone on the proliferation of osteoblast-like cells; A possible involvement of cyclic AMPBiochemical and Biophysical Research Communications, 1985
- Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart diseaseThe Journal of Pediatrics, 1980
- EVIDENCE THAT THE BONE RESORPTION-STIMULATING FACTOR PRODUCED BY MOUSE FIBROSARCOMA CELLS IS PROSTAGLANDIN E2The Journal of Experimental Medicine, 1972